Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials

• Soheil Hassanipour,
• Morteza Arab-Zozani,
• Bahman Amani,
• Forough Heidarzad,
• Mohammad Fathalipour,
• Rudolph Martinez-de-Hoyo

Affiliations

Soheil Hassanipour

Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences

Morteza Arab-Zozani

Social Determinants of Health Research Center, Birjand University of Medical Sciences

Bahman Amani

Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences

Forough Heidarzad

Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences

Mohammad Fathalipour

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Hormozgan University of Medical Sciences

Rudolph Martinez-de-Hoyo

MSN Labs Americas